UniSuper Management Pty Ltd Buys 37,802 Shares of Kenvue Inc. (NYSE:KVUE)

UniSuper Management Pty Ltd grew its stake in shares of Kenvue Inc. (NYSE:KVUE) by 3.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,248,543 shares of the company’s stock after acquiring an additional 37,802 shares during the period. UniSuper Management Pty Ltd’s holdings in Kenvue were worth $26,656,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in KVUE. Advisors Asset Management Inc. boosted its position in shares of Kenvue by 8.3% in the third quarter. Advisors Asset Management Inc. now owns 20,371 shares of the company’s stock valued at $471,000 after acquiring an additional 1,559 shares during the period. Larson Financial Group LLC boosted its holdings in Kenvue by 81.8% in the 3rd quarter. Larson Financial Group LLC now owns 18,830 shares of the company’s stock valued at $436,000 after purchasing an additional 8,473 shares during the period. Daiwa Securities Group Inc. grew its position in shares of Kenvue by 10.4% during the 3rd quarter. Daiwa Securities Group Inc. now owns 253,455 shares of the company’s stock worth $5,862,000 after purchasing an additional 23,936 shares in the last quarter. Independent Advisor Alliance increased its holdings in shares of Kenvue by 10.8% during the third quarter. Independent Advisor Alliance now owns 51,003 shares of the company’s stock worth $1,180,000 after purchasing an additional 4,960 shares during the period. Finally, The Manufacturers Life Insurance Company raised its position in shares of Kenvue by 5.5% in the third quarter. The Manufacturers Life Insurance Company now owns 2,138,576 shares of the company’s stock valued at $49,465,000 after buying an additional 110,849 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on KVUE. Royal Bank of Canada reissued a “sector perform” rating and set a $24.00 price target on shares of Kenvue in a research report on Monday, February 3rd. Barclays decreased their price target on Kenvue from $23.00 to $21.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Canaccord Genuity Group upped their price objective on shares of Kenvue from $24.00 to $29.00 and gave the stock a “buy” rating in a research report on Wednesday, March 5th. Piper Sandler raised their target price on shares of Kenvue from $24.00 to $27.00 and gave the company an “overweight” rating in a report on Monday, February 24th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Kenvue from a “buy” rating to a “hold” rating and cut their price target for the stock from $25.00 to $24.00 in a report on Thursday, December 12th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $23.85.

Kenvue Stock Performance

NYSE:KVUE opened at $23.40 on Thursday. The stock’s 50-day moving average is $22.22 and its 200-day moving average is $22.45. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $24.46. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. The stock has a market cap of $44.72 billion, a P/E ratio of 44.15, a price-to-earnings-growth ratio of 2.62 and a beta of 1.25.

Kenvue (NYSE:KVUE) last posted its earnings results on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. Equities research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th were given a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a yield of 3.50%. The ex-dividend date was Wednesday, February 12th. Kenvue’s dividend payout ratio is currently 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.